A Review on Progress and Potential of Machine Learning and AI in Pharmaceutical Development

The integration of artificial intelligence (AI) in pharmaceutical technology represents a transformative shift in how drugs are discovered, developed, and manufactured. Recent advancements in machine learning algorithms, deep neural networks, and computational power have accelerated drug discovery timelines and enhanced manufacturing efficiency. AI technologies have demonstrated remarkable capabilities in target identification, lead optimization, and prediction of drug-protein interactions. In pharmaceutical manufacturing, AI-driven process analytical technology (PAT) systems optimize production parameters, ensure quality control, and enable real-time monitoring of critical process parameters. The implementation of AI in pharmaceutical analysis has revolutionized quality testing procedures, automated analytical processes, and improved predictive maintenance strategies. Despite these advances, the pharmaceutical industry faces challenges in AI adoption, including data quality concerns, regulatory compliance, and technical implementation barriers. Current regulatory frameworks are evolving to accommodate AI-based systems while maintaining stringent quality and safety standards. Looking ahead, emerging technologies such as quantum computing and federated learning promise to further enhance AI capabilities in drug development. The convergence of AI with other cutting-edge technologies positions the pharmaceutical industry for unprecedented innovation in therapeutic development and manufacturing excellence. The aim of this review is to study about the current state, applications, challenges, and future trajectory of AI in pharmaceutical technology, emphasizing its role in shaping the future of medicine.

• Publication year

  2025

• Venue

  Journal of Pharma Insights and Research

• Publication date

  2025-04-05

• Fields of study

  Not labeled

• Identifiers
  DOI 10.69613/8pyky553
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Artificial Intelligence in Drug Discovery and Development

  2024cited by this paper
• AI-Driven Natural Language Processing in Healthcare: Transforming Patient-Provider Communication

  2024cited by this paper
• Highly accurate protein structure prediction with AlphaFold

  2021cited by this paper
• A Deep Learning Approach to Antibiotic Discovery.

  2020cited by this paper
• Improved protein structure prediction using potentials from deep learning

  2020cited by this paper
• Review of Real-Time Release Testing of Pharmaceutical Tablets: State-of-the Art, Challenges and Future Perspective.

  2020cited by this paper
• Artificial intelligence in COVID-19 drug repurposing

  2020cited by this paper
• Artificial Intelligence in Drug Discovery

  2020cited by this paper
• Artificial intelligence in drug development: present status and future prospects.

  2019cited by this paper
• Deep learning enables rapid identification of potent DDR1 kinase inhibitors

  2019cited by this paper
• A perspective on Quality-by-Control (QbC) in pharmaceutical continuous manufacturing

  2019cited by this paper
• Monitoring and Advanced Control of Crystallization Processes

  2019cited by this paper
• Deep learning for molecular generation.

  2019cited by this paper
• Applications of machine learning in drug discovery and development

  2019cited by this paper
• Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.

  2019cited by this paper
• Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

  2018cited by this paper
• Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era

  2018cited by this paper
• Artificial Intelligence in Drug Discovery and Development

  2018cited by this paper
• Drug repurposing: progress, challenges and recommendations

  2018cited by this paper
• Deep Learning-A Technology With the Potential to Transform Health Care.

  2018cited by this paper
• Machine learning in chemoinformatics and drug discovery.

  2018cited by this paper
• Recent applications of machine learning in medicinal chemistry.

  2018cited by this paper
• The rise of deep learning in drug discovery.

  2018cited by this paper
• Regulatory Perspectives on Continuous Pharmaceutical Manufacturing: Moving From Theory to Practice: September 26-27, 2016, International Symposium on the Continuous Manufacturing of Pharmaceuticals.

  2017cited by this paper
• Quality by design approach: Regulatory need

  2017cited by this paper
• The future of pharmaceutical quality and the path to get there.

  2017cited by this paper
• From machine learning to deep learning: progress in machine intelligence for rational drug discovery.

  2017cited by this paper
• Automating drug discovery

  2017cited by this paper
• Planning chemical syntheses with deep neural networks and symbolic AI

  2017cited by this paper
• The Next Era: Deep Learning in Pharmaceutical Research

  2016cited by this paper
• Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data.

  2016cited by this paper
• Innovation in the pharmaceutical industry: New estimates of R&D costs.

  2016influential reference
• Deep Learning in Drug Discovery

  2016cited by this paper
• Assessment of Recent Process Analytical Technology (PAT) Trends: A Multiauthor Review

  2015cited by this paper
• Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production

  2015cited by this paper
• The Future of Pharmaceutical Manufacturing Sciences

  2015cited by this paper
• Machine-learning approaches in drug discovery: methods and applications.

  2015cited by this paper
• Understanding Pharmaceutical Quality by Design

  2014cited by this paper
• QSAR modeling: where have you been? Where are you going to?

  2014cited by this paper
• QbD/PAT for bioprocessing: moving from theory to implementation

  2014cited by this paper
• Recent advances in the monitoring, modelling and control of crystallization systems

  2013cited by this paper
• Latent variable modeling to assist the implementation of Quality-by-Design paradigms in pharmaceutical development and manufacturing: a review.

  2013cited by this paper
• System-wide hybrid MPC-PID control of a continuous pharmaceutical tablet manufacturing process via direct compaction.

  2013cited by this paper
• Quality in the pharmaceutical industry – A literature review

  2013cited by this paper
• Quality by Design Approach: Application of Artificial Intelligence Techniques of Tablets Manufactured by Direct Compression

  2012cited by this paper
• Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT).

  2012cited by this paper
• Improvement of manufacturing operations at a pharmaceutical company

  2011cited by this paper
• Advancing Regulatory Science

  2011cited by this paper
• Computer Aided Drug Design: A Review

  2011cited by this paper
• Regulatory Requirements for Drug Development and Approval in United States: A Review

  2011cited by this paper
• Multivariate data analysis in pharmaceutics: a tutorial review.

  2011cited by this paper
• Pharmaceutical engineering science—New approaches to pharmaceutical development and manufacturing

  2010cited by this paper
• Model-based computer-aided framework for design of process monitoring and analysis systems

  2009cited by this paper
• Quality by design for biopharmaceuticals

  2009cited by this paper
• Active Learning Literature Survey

  2009cited by this paper
• Artificial intelligence in pharmaceutical product formulation: Neural computing

  2009cited by this paper
• A Framework for the Development of Design and Control Spaces

  2008cited by this paper
• Quality by Design: Concepts for ANDAs

  2008cited by this paper
• Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control

  2008cited by this paper
• A review of near infrared spectroscopy and chemometrics in pharmaceutical technologies.

  2007cited by this paper
• The Process Analytical Technology initiative and multivariate process analysis, monitoring and control

  2006cited by this paper
• Simple assessment of homogeneity in pharmaceutical mixing processes using a near-infrared reflectance probe and control charts.

  2006cited by this paper
• Guidance for Industry PAT — A Framework for Innovative Pharmaceutical Development , Manufacturing , and Quality Assurance

  2004cited by this paper
• Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research.

  2000cited by this paper
• Application of artificial neural networks (ANN) in the development of solid dosage forms.

  1997cited by this paper

• AI-Driven Pharmaceutical Data Analysis Tool for Drug Formulation Development

  2025cites this paper